Skip to content
Triangle logo TriangleGet started
← Full study record

NCT04925193 · OUTCOME

Overall Survival

Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma · Source last updated 2026-04-07

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
EOT + 2 years, or date of progression (whichever comes first)

What was measured

To evaluate the duration of overall survival achieved with physician's choice selinexor-based combination therapy.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
anticipated Posting Date
2026-08
denom Units Selected
Participants
description
To evaluate the duration of overall survival achieved with physician's choice selinexor-based combination therapy.
reporting Status
NOT_POSTED
time Frame
EOT + 2 years, or date of progression (whichever comes first)
title
Overall Survival
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice